Biondvax Pharmaceuticals Ltd - ADR

NASDAQ:BVXV   3:59:53 PM EDT
1.16
-0.01 (-0.86%)
Earnings Announcements

Biondvax Announces First Quarter 2022 Financial Results And Provides Business Update

Published: 06/01/2022 11:53 GMT
Biondvax Pharmaceuticals Ltd - ADR (BVXV) - Biondvax Announces First Quarter 2022 Financial Results and Provides Business Update.
Biondvax Pharmaceuticals Ltd - As of March 31, 2022, Biondvax Had Cash and Cash Equivalents of Nis 48.9 Million ($15.4 Million).
Biondvax Pharmaceuticals Ltd - Qtrly Loss per Share $0.005.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.01

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.01

More details on our Analysts Page.